IMP3 combined with CD44s, a novel predictor for prognosis of patients with hepatocellular carcinoma. [electronic resource]
Producer: 20140626Description: 883-93 p. digitalISSN:- 1432-1335
- Adult
- Aged
- Biomarkers, Tumor -- genetics
- Blotting, Western
- Carcinoma, Hepatocellular -- metabolism
- Case-Control Studies
- Cell Movement
- Cell Proliferation
- Female
- Follow-Up Studies
- Humans
- Hyaluronan Receptors -- genetics
- Immunoenzyme Techniques
- Liver -- metabolism
- Liver Neoplasms -- metabolism
- Male
- Middle Aged
- Neoplasm Grading
- Neoplasm Recurrence, Local -- genetics
- Neoplasm Staging
- Prognosis
- RNA, Messenger -- genetics
- RNA-Binding Proteins -- genetics
- Real-Time Polymerase Chain Reaction
- Retrospective Studies
- Reverse Transcriptase Polymerase Chain Reaction
- Survival Rate
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.